UA42722C2 - Сульфіди, сульфоксиди або сульфони, або їх фармацевтично прийнятні солі і фармацевтична композиція, що їх містить - Google Patents

Сульфіди, сульфоксиди або сульфони, або їх фармацевтично прийнятні солі і фармацевтична композиція, що їх містить

Info

Publication number
UA42722C2
UA42722C2 UA95114926A UA95114926A UA42722C2 UA 42722 C2 UA42722 C2 UA 42722C2 UA 95114926 A UA95114926 A UA 95114926A UA 95114926 A UA95114926 A UA 95114926A UA 42722 C2 UA42722 C2 UA 42722C2
Authority
UA
Ukraine
Prior art keywords
sulphoxides
sulphones
pharmaceutically acceptable
acceptable salts
sulphides
Prior art date
Application number
UA95114926A
Other languages
English (en)
Russian (ru)
Inventor
Поль Джон Херріс
Поль Джон Херрис
Дейвід Джон Хіль
Дейвид Джон Хиль
Original Assignee
Кноль Акціенгезельшафт
Кноль Акциенгезельшафт
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Кноль Акціенгезельшафт, Кноль Акциенгезельшафт filed Critical Кноль Акціенгезельшафт
Publication of UA42722C2 publication Critical patent/UA42722C2/uk

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C323/00—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups
    • C07C323/23—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and nitrogen atoms, not being part of nitro or nitroso groups, bound to the same carbon skeleton
    • C07C323/24—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and nitrogen atoms, not being part of nitro or nitroso groups, bound to the same carbon skeleton having the sulfur atoms of the thio groups bound to acyclic carbon atoms of the carbon skeleton
    • C07C323/25—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and nitrogen atoms, not being part of nitro or nitroso groups, bound to the same carbon skeleton having the sulfur atoms of the thio groups bound to acyclic carbon atoms of the carbon skeleton the carbon skeleton being acyclic and saturated
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/08—Antiepileptics; Anticonvulsants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16—Anti-Parkinson drugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/22—Anxiolytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/26—Psychostimulants, e.g. nicotine, ***e
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C317/00—Sulfones; Sulfoxides
    • C07C317/26—Sulfones; Sulfoxides having sulfone or sulfoxide groups and nitrogen atoms, not being part of nitro or nitroso groups, bound to the same carbon skeleton
    • C07C317/28—Sulfones; Sulfoxides having sulfone or sulfoxide groups and nitrogen atoms, not being part of nitro or nitroso groups, bound to the same carbon skeleton with sulfone or sulfoxide groups bound to acyclic carbon atoms of the carbon skeleton
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2601/00—Systems containing only non-condensed rings
    • C07C2601/04—Systems containing only non-condensed rings with a four-membered ring

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Psychiatry (AREA)
  • Pain & Pain Management (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Child & Adolescent Psychology (AREA)
  • Psychology (AREA)
  • Hospice & Palliative Care (AREA)
  • Obesity (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Steroid Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)

Abstract

Винахід належить до нових сірковмісних органічних сполук, що мають біологічну активність, зокрема, до сульфідів, сульфоксидів або сульфонів та їх фармавцевтично прийнятних солей, а також до фармацевтичної композиції, яка їх містить.
UA95114926A 1993-05-12 1994-05-07 Сульфіди, сульфоксиди або сульфони, або їх фармацевтично прийнятні солі і фармацевтична композиція, що їх містить UA42722C2 (uk)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB939309749A GB9309749D0 (en) 1993-05-12 1993-05-12 Therapeutic agents
PCT/EP1994/001494 WO1994026704A1 (en) 1993-05-12 1994-05-07 1-arylcycloalkyl sulphides, sulphoxides and sulphones for the treatment of depression, anxiety and parkinson's disease

Publications (1)

Publication Number Publication Date
UA42722C2 true UA42722C2 (uk) 2001-11-15

Family

ID=10735317

Family Applications (1)

Application Number Title Priority Date Filing Date
UA95114926A UA42722C2 (uk) 1993-05-12 1994-05-07 Сульфіди, сульфоксиди або сульфони, або їх фармацевтично прийнятні солі і фармацевтична композиція, що їх містить

Country Status (29)

Country Link
US (1) US5652271A (uk)
EP (1) EP0715620B1 (uk)
JP (2) JP3606326B2 (uk)
KR (1) KR100295264B1 (uk)
AT (1) ATE172719T1 (uk)
AU (1) AU681669B2 (uk)
BG (1) BG61913B1 (uk)
BR (2) BR9406577A (uk)
CZ (1) CZ290711B6 (uk)
DE (1) DE69414264T2 (uk)
DK (1) DK0715620T3 (uk)
ES (1) ES2124411T3 (uk)
FI (1) FI955429A (uk)
GB (1) GB9309749D0 (uk)
HU (1) HU211124A9 (uk)
IL (1) IL109635A (uk)
LV (1) LV11320A (uk)
MY (1) MY110773A (uk)
NO (1) NO305165B1 (uk)
NZ (1) NZ266776A (uk)
PH (1) PH30418A (uk)
PL (1) PL176400B1 (uk)
RO (1) RO115519B1 (uk)
RU (1) RU2135467C1 (uk)
SK (1) SK281257B6 (uk)
TW (1) TW318833B (uk)
UA (1) UA42722C2 (uk)
WO (1) WO1994026704A1 (uk)
ZA (1) ZA943241B (uk)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19518988A1 (de) * 1995-05-29 1996-12-05 Basf Ag Verwendung arylsubstituierter Cyclobutylalkylamine zur Behandlung der Fettleibigkeit
GB9524681D0 (en) 1995-12-02 1996-01-31 Knoll Ag Chemical process
GB9915617D0 (en) * 1999-07-05 1999-09-01 Knoll Ag Therapeutic agents
US20030224045A1 (en) * 2002-05-29 2003-12-04 Chien-Hsuan Han Combination immediate release sustained release levodopa/carbidopa dosage forms
US20060013875A1 (en) * 2002-05-29 2006-01-19 Impax Laboratories, Inc. Combination immediate release controlled release levodopa/carbidopa dosage forms
US7094427B2 (en) * 2002-05-29 2006-08-22 Impax Laboratories, Inc. Combination immediate release controlled release levodopa/carbidopa dosage forms
US20040166159A1 (en) * 2002-05-29 2004-08-26 Chien-Hsuan Han Pharmaceutical dosage forms having immediate and controlled release properties that contain an aromatic amino acid decarboxylase inhibitor and levodopa
KR101374593B1 (ko) * 2006-04-26 2014-03-17 토야마 케미칼 컴퍼니 리미티드 알킬에테르 유도체 또는 그 염을 함유하는 신경세포 신생유도제 및 정신장해 치료제
US10987313B2 (en) 2013-10-07 2021-04-27 Impax Laboratories, Llc Muco-adhesive, controlled release formulations of levodopa and/or esters of levodopa and uses thereof
JP6506271B2 (ja) 2013-10-07 2019-04-24 インパックス ラボラトリーズ、 インコーポレイテッドＩｍｐａｘ Ｌａｂｏｒａｔｏｒｉｅｓ， Ｉｎｃ． レボドパ及び／又はレボドパのエステルの粘膜付着性制御放出配合物、並びにその使用
US11986449B2 (en) 2020-12-22 2024-05-21 Amneal Pharmaceuticals Llc Levodopa dosing regimen

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IE52768B1 (en) * 1981-04-06 1988-02-17 Boots Co Ltd 1-arylcyclobutylalkylamine compounds useful as therapeutic agents
IE56000B1 (en) * 1982-09-30 1991-03-13 Boots Co Plc 1-arylcyclobutylalkylamine compounds
GB8501192D0 (en) * 1985-01-17 1985-02-20 Boots Co Plc Therapeutic agents
GB8704777D0 (en) * 1987-02-28 1987-04-01 Boots Co Plc Medical treatment

Also Published As

Publication number Publication date
NO954542D0 (no) 1995-11-10
LV11320A (lv) 1996-06-20
PH30418A (en) 1997-05-09
BR1100306A (pt) 2002-04-02
GB9309749D0 (en) 1993-06-23
PL176400B1 (pl) 1999-05-31
AU6843394A (en) 1994-12-12
DK0715620T3 (da) 1999-07-05
RU2135467C1 (ru) 1999-08-27
US5652271A (en) 1997-07-29
IL109635A (en) 1998-03-10
NZ266776A (en) 1998-02-26
JP2004331669A (ja) 2004-11-25
MY110773A (en) 1999-03-31
SK281257B6 (sk) 2001-01-18
KR100295264B1 (ko) 2001-09-17
BR9406577A (pt) 1996-01-30
WO1994026704A1 (en) 1994-11-24
ATE172719T1 (de) 1998-11-15
BG100127A (bg) 1996-07-31
CZ290711B6 (cs) 2002-09-11
PL311628A1 (en) 1996-03-04
NO954542L (no) 1996-01-10
IL109635A0 (en) 1994-11-11
HU211124A9 (en) 1995-10-30
RO115519B1 (ro) 2000-03-30
NO305165B1 (no) 1999-04-12
BG61913B1 (bg) 1998-09-30
FI955429A (fi) 1996-01-03
SK140795A3 (en) 1996-09-04
DE69414264T2 (de) 1999-03-25
JPH08510222A (ja) 1996-10-29
FI955429A0 (fi) 1995-11-10
CZ293695A3 (en) 1996-06-12
AU681669B2 (en) 1997-09-04
TW318833B (uk) 1997-11-01
ES2124411T3 (es) 1999-02-01
JP3606326B2 (ja) 2005-01-05
EP0715620B1 (en) 1998-10-28
EP0715620A1 (en) 1996-06-12
ZA943241B (en) 1994-11-14
DE69414264D1 (de) 1998-12-03

Similar Documents

Publication Publication Date Title
BG102425A (en) (methylsulphonyl)phenyl-2-(5h)-furanons as cyclooxygenase-2-inhibitors
NZ240230A (en) Mercaptoacetylamide derivatives; preparation, use and pharmaceutical compositions thereof
IL128425A0 (en) Taxane derivatives their preparation and pharmaceutical compositions containing them
OA09772A (en) "mometasone furoate monohydrate, process for making same and pharmaceutical compositions".
IL113812A0 (en) Copolymer-1, pharmaceutical compositions containing it and its use
IL136044A (en) 2-aminoacetamide derivatives and pharmaceutical compositions containing the same
BG103947A (en) Derivatives of 9-oxymerythromycin
NZ247201A (en) Substituted sulphonylamido- or sulphonamidocarbonyl-pyridine-2-carboxamide derivatives and pharmaceutical compositions
IL109720A (en) N-alkylthio polyamine derivatives and radioprotective compositions containing them
UA66766C2 (uk) Антимікробна фармацевтична композиція на основі гіалуронатного асоціату цинку або кобальту, спосіб її одержання та спосіб лікування
EP0831871A4 (en) SIMILAR FACTOR TO RELAXIN, ITS METHODS AND USES
NZ511085A (en) Oral pharmaceutical compositions containing buprenorphin
UA42722C2 (uk) Сульфіди, сульфоксиди або сульфони, або їх фармацевтично прийнятні солі і фармацевтична композиція, що їх містить
UA42733C2 (uk) Похідні біснафталіміду та їх фармацевтично прийнятні кислотно-адитивні солі, фармацевтична композиція з цитотоксичною активністю, яка їх містить
MY120550A (en) Substituted 1,2,3,4,5,6-hexahydro-2,6-methano-3-benzazocin-10-ols, processes for preparing them and their use as pharmaceutical compositions.
CA2047802A1 (en) Pharmaceutical compositions
BG103306A (en) Liquid allendronate compositions
ES2013669A6 (es) Composiciones poliolefinicas para peliculas fotobiodegradables.
ES8504774A1 (es) Procedimiento para preparar derivados de 2-piperacinil-quinazolina
GB2258397A (en) Pharmaceutical compositions containing amethocaine
AU8452891A (en) Calcium uptake inhibitors
IL111018A0 (en) triaryl ethylene derivatives and pharmaceutical compositions containing them
GR3023941T3 (en) Cyclic derivatives of angiopeptin, their preparation and their pharmaceutical compositions.
AU8452791A (en) 1-phenyl-3-aryl-2-propyne-1-ones
MY100083A (en) Diazepinoindoles, their production and pharmaceutical compositions containing them.